Varicella-Zoster Virus (Chickenpox): Nursing, Laboratory, and Epidemiological Perspectives
Abstract
Background: Varicella (chickenpox) is a highly contagious viral disease caused by the varicellazoster virus (VZV), characterized by a generalized vesicular rash and systemic symptoms. Despite widespread vaccination, varicella continues to pose clinical and public health challenges, particularly among highrisk populations such as adults, pregnant women, neonates, and immunocompromised individuals.
Aim: This article aims to comprehensively review varicella from nursing, laboratory, and epidemiological perspectives, emphasizing etiology, transmission, clinical features, diagnosis, management, prevention, and public health implications.
Methods: A descriptive narrative review approach was used, synthesizing established clinical, epidemiological, and laboratory data on VZV infection. Key aspects reviewed include pathophysiology, histopathology, clinical presentation, diagnostic modalities, treatment strategies, complications, and prevention through vaccination.
Results: Varicella is primarily transmitted via airborne droplets and direct contact with vesicular fluid. While generally selflimiting in children, severe disease and complications such as pneumonia, encephalitis, and secondary bacterial infections are more common in adults and immunocompromised hosts. Polymerase chain reaction testing is the most sensitive diagnostic method. Antiviral therapy reduces disease severity in highrisk patients, and vaccination has significantly decreased incidence, hospitalizations, and mortality.
Conclusion: Varicella remains a clinically relevant disease requiring ongoing surveillance, vaccination advocacy, early diagnosis, and interprofessional collaboration to minimize complications and transmission.
Full text article
References
Shrim A, Koren G, Yudin MH, Farine D. No. 274-Management of Varicella Infection (Chickenpox) in Pregnancy. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC. 2018 Aug:40(8):e652-e657. doi: 10.1016/j.jogc.2018.05.034.
Pereira L. Congenital Viral Infection: Traversing the Uterine-Placental Interface. Annual review of virology. 2018 Sep 29:5(1):273-299. doi: 10.1146/annurev-virology-092917-043236.
Kasabwala K, Wise GJ. Varicella-zoster virus and urologic practice: a case-based review. The Canadian journal of urology. 2018 Jun:25(3):9301-9306
Al-Turab M, Chehadeh W. Varicella infection in the Middle East: Prevalence, complications, and vaccination. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. 2018:23():19. doi: 10.4103/jrms.JRMS_979_17.
Dowell SF, Bresee JS. Severe varicella associated with steroid use. Pediatrics. 1993 Aug:92(2):223-8
Longbottom K, Lyall H. Neonatal varicella. Archives of disease in childhood. 2024 Jul 18:109(8):610-615. doi: 10.1136/archdischild-2022-324820.
Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics. 2008 Sep:122(3):e744-51. doi: 10.1542/peds.2008-0567.
Haider M, Novice T, Engers D, Burman I. Never Too Old: A Case of Chicken Pox in an Eighty-One-Year-Old Patient. The American journal of medicine. 2022 Jul:135(7):851-852. doi: 10.1016/j.amjmed.2022.02.031.
Rice ME, Bannerman M, Marin M, Lopez AS, Lewis MM, Stamatakis CE, Regan JJ. Maritime varicella illness and death reporting, U.S., 2010-2015. Travel medicine and infectious disease. 2018 May-Jun:23():27-33. doi: 10.1016/j.tmaid.2018.04.001.
Schmader K. Herpes Zoster. Clinics in geriatric medicine. 2016 Aug:32(3):539-53. doi: 10.1016/j.cger.2016.02.011.
Bakker KM, Martinez-Bakker ME, Helm B, Stevenson TJ. Digital epidemiology reveals global childhood disease seasonality and the effects of immunization. Proceedings of the National Academy of Sciences of the United States of America. 2016 Jun 14:113(24):6689-94. doi: 10.1073/pnas.1523941113.
Rockley PF, Tyring SK. Pathophysiology and clinical manifestations of varicella zoster virus infections. International journal of dermatology. 1994 Apr:33(4):227-32
Freer G, Pistello M. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies. The new microbiologica. 2018 Apr:41(2):95-105
Dayan RR, Peleg R. Herpes zoster - typical and atypical presentations. Postgraduate medicine. 2017 Aug:129(6):567-571. doi: 10.1080/00325481.2017.1335574.
Inata K, Miyazaki D, Uotani R, Shimizu D, Miyake A, Shimizu Y, Inoue Y. Effectiveness of real-time PCR for diagnosis and prognosis of varicella-zoster virus keratitis. Japanese journal of ophthalmology. 2018 Jul:62(4):425-431. doi: 10.1007/s10384-018-0604-7.
Onyango CO, Loparev V, Lidechi S, Bhullar V, Schmid DS, Radford K, Lo MK, Rota P, Johnson BW, Munoz J, Oneko M, Burton D, Black CM, Neatherlin J, Montgomery JM, Fields B. Evaluation of a TaqMan Array Card for Detection of Central Nervous System Infections. Journal of clinical microbiology. 2017 Jul:55(7):2035-2044. doi: 10.1128/JCM.02469-16.
Harrington D, Haque T. Varicella Zoster Immunoglobulin G (VZIG)-Do current guidelines advocate overuse? Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2018 Jun:103():25-26. doi: 10.1016/j.jcv.2018.03.007.
Poole CL, James SH. Antiviral Therapies for Herpesviruses: Current Agents and New Directions. Clinical therapeutics. 2018 Aug:40(8):1282-1298. doi: 10.1016/j.clinthera.2018.07.006.
Hayward K, Cline A, Stephens A, Street L. Management of herpes zoster (shingles) during pregnancy. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2018 Oct:38(7):887-894. doi: 10.1080/01443615.2018.1446419.
Maranich AM, Rajnik M. Varicella-specific immunoglobulin G titers in commercial intravenous immunoglobulin preparations. Pediatrics. 2009 Sep:124(3):e484-8. doi: 10.1542/peds.2009-0047.
Rasizadeh R, Shamekh A, Shiri Aghbash P, Bannazadeh Baghi H. Comparison of human monkeypox, chickenpox and smallpox: a comprehensive review of pathology and dermatological manifestations. Current medical research and opinion. 2023 May:39(5):751-760. doi: 10.1080/03007995.2023.2200122.
Buerke M, Böttger P, Lemm H. [Mpox-diagnosis, treatment, immunization, and prognosis]. Medizinische Klinik, Intensivmedizin und Notfallmedizin. 2025 Mar:120(2):141-144. doi: 10.1007/s00063-024-01198-w.
Onukak AE, Nga CN, Ubani BC, Umoinwek E, Umoette N. Mpox and Chicken Pox Coinfection Complicated by Acute Urinary Retention: A Case Report. West African journal of medicine. 2023 Aug 28:40(8):873-876
Hall S, Maupin T, Seward J, Jumaan AO, Peterson C, Goldman G, Mascola L, Wharton M. Second varicella infections: are they more common than previously thought? Pediatrics. 2002 Jun:109(6):1068-73
Bhardwaj LM, Borthakur S, Bhattacharyya PC. Simultaneous Occurrence of Chicken Pox and Herpes Zoster with Facial Nerve Palsy in Immunocompetent Patient. The Journal of the Association of Physicians of India. 2022 Aug:70(8):11-12. doi: 10.5005/japi-11001-0075.
Charlier C, Anselem O, Caseris M, Lachâtre M, Tazi A, Driessen M, Pinquier D, Le Cœur C, Saunier A, Bergamelli M, Gibert Vanspranghels R, Chosidow A, Cazanave C, Alain S, Faure K, Birgy A, Dubos F, Lesprit P, Guinaud J, Cohen R, Decousser JW, Grimprel E, Huissoud C, Blanc J, Kayem G, Vuotto F, Vauloup-Fellous C. Prevention and management of VZV infection during pregnancy and the perinatal period. Infectious diseases now. 2024 Jun:54(4):104857. doi: 10.1016/j.idnow.2024.104857.
Tommasi C, Drousioti A, Breuer J. The live attenuated varicella-zoster virus vaccine vOka: Molecular and cellular biology of its skin attenuation. Human vaccines & immunotherapeutics. 2025 Dec:21(1):2482286. doi: 10.1080/21645515.2025.2482286.
Wooding EL, Kadambari S, Warris A. Varicella: is it time for a global vaccination programme? Archives of disease in childhood. 2025 Jul 18:110(8):586-591. doi: 10.1136/archdischild-2024-327593.
Wang X, Zhang X, Yu Z, Zhang Q, Huang D, Yu S. Long-term outcomes of varicella zoster virus infection-related myelitis in 10 immunocompetent patients. Journal of neuroimmunology. 2018 Aug 15:321():36-40. doi: 10.1016/j.jneuroim.2018.05.005.
McRae JE, Quinn HE, Macartney K. Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2015: Prospective hospital-based surveillance for serious paediatric conditions. Communicable diseases intelligence quarterly report. 2017 Sep 1:41(3):E275-E283
Dommasch ED, Joyce CJ, Mostaghimi A. Trends in Nationwide Herpes Zoster Emergency Department Utilization From 2006 to 2013. JAMA dermatology. 2017 Sep 1:153(9):874-881. doi: 10.1001/jamadermatol.2017.1546.
Ogunjimi B, Van den Bergh J, Meysman P, Heynderickx S, Bergs K, Jansens H, Leuridan E, Vorsters A, Goossens H, Laukens K, Cools N, Van Tendeloo V, Hens N, Van Damme P, Smits E, Beutels P. Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox. Scientific reports. 2017 Apr 24:7(1):1077. doi: 10.1038/s41598-017-01024-8.
Ogunjimi B, Van Damme P, Beutels P. Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review. PloS one. 2013:8(6):e66485. doi: 10.1371/journal.pone.0066485.
Meylan P, Gerber S, Kempf W, Nadal D, Swiss Herpes Management Forum. [Swiss recommendations for the management of varicella-zoster virus infections]. Revue medicale suisse. 2007 Sep 19:3(125):2116-22, 2124-9
Authors
Copyright (c) 2025 Abbas Mohammed Alnami, Ahmed Ibrahim Hussein Alnajie, Mohammed Ahmed AMohammed Okayri, Layla Yahya Mansour Matary, Kamlah Mortada Ahmad Alhazm, Fatimah Ahmad Abdo Suraihi, Nouf Ali Ahmed Nahari, Hussain Ebrahim Tawashi, Rajaa Ibrahim Ahmed Alakrash, Muteeb Mohamed Alasiri, Abdulelah Omar Mousa Sharwani, Maram Khalid Alatwan
This work is licensed under a Creative Commons Attribution 4.0 International License.